Page last updated: 2024-08-16

1,4-bis(2-(3,5-dichloropyridyloxy))benzene and methotrexate

1,4-bis(2-(3,5-dichloropyridyloxy))benzene has been researched along with methotrexate in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Halwachs, S; Honscha, W; Schaefer, I; Seibel, P1

Other Studies

2 other study(ies) available for 1,4-bis(2-(3,5-dichloropyridyloxy))benzene and methotrexate

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Antiepileptic drugs reduce the efficacy of methotrexate chemotherapy through accelerated degradation of the reduced folate carrier by the ubiquitin-proteasome pathway.
    Chemotherapy, 2011, Volume: 57, Issue:4

    Topics: Animals; Anticonvulsants; Antimetabolites, Antineoplastic; Biosynthetic Pathways; Cell Line; Constitutive Androstane Receptor; Cytochrome P-450 Enzyme System; Drug Interactions; Half-Life; Methotrexate; Phenobarbital; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Kinase C; Pyridines; Rats; Receptors, Cytoplasmic and Nuclear; Reduced Folate Carrier Protein; Replication Protein C; Repressor Proteins; Ubiquitin

2011